Charles Albright, Ph.D. Discovery of EDIT-101 for the Treatment of Leber’s Congenital Amaurosis Type 10. Presented at Keystone Symposia on Molecular and Cellular Biology: Precision Genome Editing with Programmable Nucleases, January 28 – February 1, 2018.